ArriVent BioPharma (AVBP) Insider Trading & Ownership $17.42 -0.57 (-3.16%) Closing price 08/11/2025 03:59 PM EasternExtended Trading$17.40 -0.02 (-0.12%) As of 08/11/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ArriVent BioPharma (NASDAQ:AVBP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.58%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$18.00MNumber OfInsiders Selling(Last 3 Years)0 Get AVBP Insider Trade Alerts Want to know when executives and insiders are buying or selling ArriVent BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AVBP Insider Buying and Selling by Quarter ArriVent BioPharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/30/2024Hillhouse Investment ManagemenMajor ShareholderBuy555,555$18.00$9,999,990.00 1/30/2024Orbimed Advisors LlcDirectorBuy444,444$18.00$7,999,992.00 (Data available from 1/1/2013 forward) AVBP Insider Trading Activity - Frequently Asked Questions Who is on ArriVent BioPharma's Insider Roster? The list of insiders at ArriVent BioPharma includes Hillhouse Investment Managemen, and Orbimed Advisors Llc. Learn more on insiders at AVBP. What percentage of ArriVent BioPharma stock is owned by insiders? 18.58% of ArriVent BioPharma stock is owned by insiders. Learn more on AVBP's insider holdings. Which ArriVent BioPharma insiders have been buying company stock? The following insiders have purchased AVBP shares in the last 24 months: Hillhouse Investment Managemen ($9,999,990.00), and Orbimed Advisors Llc ($7,999,992.00). How much insider buying is happening at ArriVent BioPharma? Insiders have purchased a total of 999,999 AVBP shares in the last 24 months for a total of $17,999,982.00 bought. ArriVent BioPharma Key ExecutivesDr. Zhengbin Yao Ph.D. (Age 58)Co-Founder, Chairman, President & CEO Compensation: $791.09kDr. Stuart Lutzker M.D. (Age 63)Ph.D., Co-Founder, President of Research & Development and Director Compensation: $709.43kMs. Robin LaChapelle M.A. (Age 51)Co-Founder & COO Compensation: $586.45kMr. Winston Kung M.B.A. (Age 48)CFO & Treasurer Ms. Yang Wang Ph.D.Chief Technology OfficerMr. James Paul Kastenmayer J.D. (Age 52)Ph.D., General Counsel & Secretary Dr. Dandan Dong (Age 39)Chief Business Officer Ms. Meghna ChowdarySenior Vice President of Commercial Strategy More Insider Trading Tools from MarketBeat Related Companies Gemini Therapeutics Insider Trading Mirum Pharmaceuticals Insider Trading Amneal Pharmaceuticals Insider Trading NewAmsterdam Pharma Insider Trading Kiniksa Pharmaceuticals International Insider Trading Organon & Co. Insider Trading Arrowhead Pharmaceuticals Insider Trading Centessa Pharmaceuticals Insider Trading Recursion Pharmaceuticals Insider Trading Bausch Health Cos Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:AVBP) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy Elon put $51 million into thisChris Rowe has made legendary calls—Tesla at $13, Nvidia at $40, Bitcoin under $1,000, Amazon at 12 cents. Now...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access